Trellus Health Secures USD 5 Million in Seed Round of Financing

According to a study by the CDC, nearly 90 percent of the United States' annual health expenditure is for chronic diseases, with patients suffering from both chronic medical and mental health conditions costing twice as much

FREMONT, CA: New York-based digital health solution for chronic conditions, Trellus Health, secured USD 5 million in a Seed funding round led by Mount Sinai Health System (MSHS) and EKF Diagnostics. The company has also entered into an exclusive multi-year contract with MSHS to commercialize its patent-pending GRITT-IBDTM resilience assessment and personalized treatment methodology.

"We are transforming the way chronic conditions are treated by developing a resilience-driven connected care platform that integrates precision medicine with psychosocial care," said Monique Fayad, CEO of Trellus Health. "The traditional journey of medical care for people living with chronic conditions typically results in repeated costly, unplanned emergency room visits and hospitalizations, high rates of work absenteeism and lost productivity, as well as chronic disability and behavioral health issues. We're working to change this by focusing on building patients' resilience while integrating all partners in care, including employers, insurance plans, health systems, Trellus-certified GI providers, nurses, psychologists, and dieticians who can utilize Trellus Health's proprietary platform to effectively monitor and communicate with patients and their caregivers in real time."

According to a study by the CDC, nearly 90 percent of the United States' annual health expenditure is for chronic diseases, with patients suffering from both chronic medical and mental health conditions costing twice as much. Despite the increasing cost implications, traditional care models fail to address patients' emotional well-being with chronic conditions. There is also a lack of access to expert interdisciplinary care resources to deliver specialist level care, which is highly limited.

"Our research on over 200 IBD patients indicates that more than 70% believe their condition would be better managed if they had support for anxiety or depression," said Dubinsky, co-founder and board member. She is also a Professor of Pediatrics and Medicine, Chief of Division of Pediatric Gastroenterology, and co-director of Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai. "By personalizing care to address the psychosocial needs of all IBD patients and applying the latest evidence-based clinical approaches, we can help patients achieve disease control and enjoy a significantly improved quality of life."